サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1779885

重大疾病保険の世界市場

Critical Illness Insurance

出版日
ページ情報
英文 381 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.45円
重大疾病保険の世界市場
出版日: 2025年07月30日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 381 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

重大疾病保険の世界市場は2030年までに5,676億米ドルに達する見込み

2024年に3,888億米ドルと推定される重大疾病保険の世界市場は、2024年から2030年にかけてCAGR 6.5%で成長し、2030年には5,676億米ドルに達すると予測されます。本レポートで分析したセグメントの一つである月次保険料は、CAGR 7.2％を記録し、分析期間終了時には2,682億米ドルに達すると予測されます。四半期保険料セグメントの成長率は、分析期間中CAGR 6.8％と推定されます。

米国市場は推定1,059億米ドル、中国はCAGR 10.3％で成長予測

米国の重大疾病保険市場は、2024年に1,059億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1,178億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.2%と6.4%と予測されています。欧州では、ドイツがCAGR 4.3%で成長すると予測されています。

世界の重大疾病保険市場- 主要動向と促進要因のまとめ

なぜ重大疾病保険が人気を集めているのか？健康関連の財務リスクの増加を理解する

世界の重大疾病保険市場は、慢性疾患や生命を脅かす疾患の罹患率の増加、医療費の上昇、主要な病状に対する経済的保護に対する意識の高まりにより、大きく拡大しています。がん、脳卒中、心臓病などの非伝染性疾患が蔓延するにつれ、消費者は重大疾病治療に伴う高額な費用をカバーする包括的な保険を求めるようになっています。COVID-19パンデミックの影響は、予期せぬ医療緊急事態に直面した場合の経済的保障の重要性をさらに強調しています。さらに、可処分所得の増加や新興国における保険普及率の向上も市場の成長に寄与しています。また、雇用主は福利厚生の一環として重大疾病保険を提供し、社会人への普及を促進しています。

重大疾病保険市場の主要な保険タイプは？主要セグメントの内訳

重大疾病保険市場は、保険タイプ、補償レベル、流通チャネルに基づいて分類されます。個人向け重大疾病保険保険は依然として最も一般的であり、事前に定義された基準に基づいて特定の病状に対する金銭的補償を提供します。グループ保険は雇用主が提供することが多く、従業員の福利厚生や雇用維持戦略の強化を目指す組織の支持を集めています。重大疾病と診断された時点で一時金が支払われる一括給付プランは、治療費、収入減、ライフスタイルの調整などを柔軟にカバーできるため、広く好まれています。さらに、重大疾病保障と生命保険を組み合わせたハイブリッド保険が人気を博しており、経済的な安全性と長期的なメリットの両方を提供しています。

テクノロジーはどのように重大疾病保険業界を変革しているのか？AI、ブロックチェーン、デジタル引受の役割

保険業界は、AI、ブロックチェーン、デジタル引受ソリューションの導入により進化し、保険契約管理とリスク評価を強化しています。AIを活用した予測分析により、保険会社は個々の健康リスクをより正確に評価できるようになり、保険料の個別価格設定が可能になります。ブロックチェーン技術は保険取引の透明性と安全性を向上させ、不正行為を減らし、保険金請求処理を迅速化します。病歴分析と保険契約の承認を自動化するデジタル・アンダーライティングの利用は、保険証券の発行を加速し、顧客体験を向上させています。さらに、ウェアラブル健康機器や遠隔医療プラットフォームが重大疾病保険プランに統合され、継続的な健康モニタリングや事前のリスク管理が可能になりつつあります。

重大疾病保険市場成長の原動力は？主な市場インフルエンサーを解説

重大疾病保険市場の成長を牽引しているのは、経済的保護に対する意識の高まり、ヘルスケアコストの上昇、デジタル保険ソリューションの進歩です。新興市場における中間所得層の拡大が、重大疾病保障に対する需要の高まりにつながっています。医療保険の普及を促進する政府の取り組みも市場成長に寄与しています。さらに、シームレスな保険契約購入と保険金請求処理を提供するデジタルファーストの保険プロバイダーが増加し、アクセシビリティが向上しています。AIを活用したリスク評価と個別化された保険契約のカスタマイズが果たす役割の増大は、市場をさらに強化しています。進化する消費者ニーズと技術の進歩により、世界の重大疾病保険市場は継続的に拡大し、主要な健康リスクに対する必要不可欠な経済的保障を提供します。

セグメント

保険料（月額保険料、四半期保険料、半年保険料、年間保険料）;疾患（がん、心臓発作、脳卒中、主要臓器移植、その他の疾患）;タイプ（個人保険、家族保険）

調査対象企業の例

  • Aflac Incorporated
  • AIG（American International Group）
  • Allianz
  • Aviva
  • AXA
  • Bankers Life
  • Canada Protection Plan
  • China Life Insurance Company
  • Colonial Life & Accident Insurance Company
  • Guardian Life
  • Liberty Mutual
  • MetLife Services and Solutions, LLC
  • Mutual of Omaha
  • Ping An Insurance
  • Prudential
  • Securian Canada
  • Star Union Dai-ichi Life Insurance
  • Sun Life Financial
  • Unum Group
  • Zurich Insurance Group

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界固有のSLMをクエリする代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP30292

Global Critical Illness Insurance Market to Reach US$567.6 Billion by 2030

The global market for Critical Illness Insurance estimated at US$388.8 Billion in the year 2024, is expected to reach US$567.6 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Monthly Premium, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$268.2 Billion by the end of the analysis period. Growth in the Quarterly Premium segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$105.9 Billion While China is Forecast to Grow at 10.3% CAGR

The Critical Illness Insurance market in the U.S. is estimated at US$105.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$117.8 Billion by the year 2030 trailing a CAGR of 10.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Critical Illness Insurance Market - Key Trends & Drivers Summarized

Why Is Critical Illness Insurance Gaining Popularity? Understanding the Rise in Health-Related Financial Risks

The global critical illness insurance market has expanded significantly due to the increasing incidence of chronic and life-threatening diseases, rising healthcare costs, and growing awareness of financial protection against major medical conditions. As non-communicable diseases such as cancer, stroke, and heart disease become more prevalent, consumers are seeking comprehensive insurance policies to cover the high costs associated with critical illness treatments. The impact of the COVID-19 pandemic has further emphasized the importance of financial security in the face of unexpected medical emergencies. Additionally, rising disposable incomes and improved insurance penetration in emerging economies have contributed to market growth. Employers are also offering critical illness insurance as part of employee benefits packages, driving adoption among working professionals.

What Are the Leading Policy Types in the Critical Illness Insurance Market? A Breakdown of Key Segments

The critical illness insurance market is categorized based on policy type, coverage level, and distribution channels. Individual critical illness insurance policies remain the most common, providing financial coverage for specific medical conditions based on predefined criteria. Group policies, often offered by employers, have gained traction as organizations look to enhance employee well-being and retention strategies. Lump-sum benefit plans, which provide a one-time payout upon diagnosis of a critical illness, are widely preferred due to their flexibility in covering treatment expenses, lost income, and lifestyle adjustments. Additionally, hybrid policies that combine critical illness coverage with life insurance have gained popularity, offering both financial security and long-term benefits.

How Is Technology Transforming the Critical Illness Insurance Industry? The Role of AI, Blockchain & Digital Underwriting

The insurance industry is evolving with the adoption of AI, blockchain, and digital underwriting solutions, enhancing policy management and risk assessment. AI-powered predictive analytics enable insurers to assess individual health risks more accurately, allowing for personalized premium pricing. Blockchain technology is improving transparency and security in insurance transactions, reducing fraud and expediting claims processing. The use of digital underwriting, which automates medical history analysis and policy approvals, has accelerated policy issuance and improved customer experience. Additionally, wearable health devices and telemedicine platforms are being integrated into critical illness insurance plans, enabling continuous health monitoring and proactive risk management.

What’s Driving the Growth of the Critical Illness Insurance Market? Key Market Influencers Explained

The growth in the critical illness insurance market is driven by increasing awareness of financial protection, rising healthcare costs, and advancements in digital insurance solutions. The expansion of middle-class populations in emerging markets has led to higher demand for critical illness coverage. Government initiatives promoting health insurance penetration have also contributed to market growth. Additionally, the rising number of digital-first insurance providers, offering seamless policy purchasing and claims processing, has enhanced accessibility. The increasing role of AI-driven risk assessment and personalized policy customization is further strengthening the market. With evolving consumer needs and technological advancements, the global critical illness insurance market is set for continuous expansion, providing essential financial security against major health risks.

SCOPE OF STUDY:

The report analyzes the Critical Illness Insurance market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Premium (Monthly Premium, Quarterly Premium, Half Yearly Premium, Yearly Premium); Disease (Cancer, Heart Attack, Stroke, Major Organ Transplant, Other Diseases); Type (Individual Insurance, Family Insurance)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Aflac Incorporated
  • AIG (American International Group)
  • Allianz
  • Aviva
  • AXA
  • Bankers Life
  • Canada Protection Plan
  • China Life Insurance Company
  • Colonial Life & Accident Insurance Company
  • Guardian Life
  • Liberty Mutual
  • MetLife Services and Solutions, LLC
  • Mutual of Omaha
  • Ping An Insurance
  • Prudential
  • Securian Canada
  • Star Union Dai-ichi Life Insurance
  • Sun Life Financial
  • Unum Group
  • Zurich Insurance Group

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Critical Illness Insurance - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases and Health Conditions Drives Growing Demand for Critical Illness Insurance
    • Rising Healthcare Costs and Financial Protection Needs Expand Addressable Market for Critical Illness Insurance
    • Growing Awareness of the Importance of Health Coverage and Financial Protection Accelerates Adoption of Critical Illness Policies
    • The Shift Toward Preventive Healthcare and Early Detection Generates Demand for Critical Illness Insurance in Preventive Care Models
    • The Rise of Chronic Illnesses Such as Cancer, Heart Disease, and Diabetes Strengthens the Case for Specialized Critical Illness Coverage
    • Surge in Aging Populations Across Developed Markets Creates New Growth Opportunities for Critical Illness Insurance Products
    • Increasing Focus on Health and Wellness Programs and Risk Reduction Measures Drives Growth in Complementary Critical Illness Coverage
    • Technological Advancements in Health Monitoring Devices and Wearables Drive Personalized and Flexible Critical Illness Insurance Plans
    • Growing Awareness and Concern About Financial Implications of Serious Illnesses Expands Market for Critical Illness Coverage
    • Integration of Critical Illness Insurance with Other Health and Life Insurance Products Generates New Market Opportunities for Bundled Solutions
    • Expansion of Digital and Mobile Health Insurance Solutions Drives Accessibility and Convenience in Critical Illness Coverage
    • Increasing Demand for Short-Term and Flexible Insurance Plans Strengthens the Market for Tailored Critical Illness Insurance Products
    • Focus on Global Healthcare Access and Affordability Creates New Markets for Low-Cost Critical Illness Insurance in Emerging Economies
    • Regulatory Changes and Mandates in Health Insurance Policies Boosts the Adoption of Critical Illness Insurance Products
    • Rising Popularity of Employer-Sponsored Health Benefits and Corporate Wellness Programs Generates Demand for Group Critical Illness Insurance Plans
    • The Shift Toward More Transparent and Customer-Centric Insurance Models Expands Adoption of Critical Illness Insurance in Retail and Online Channels
    • Increasing Competition Among Insurers to Provide Comprehensive Coverage Drives Innovation in Critical Illness Insurance Plans
    • Integration of Artificial Intelligence and Data Analytics in Insurance Underwriting Enhances Personalization and Risk Assessment for Critical Illness Products
    • Increasing Incidences of Mental Health Issues and Psychological Disorders Expands Market for Comprehensive Critical Illness Coverage
    • Rising Focus on Family and Caregiver Support in Health Insurance Plans Expands Critical Illness Coverage to Include Long-Term Care Benefits
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Critical Illness Insurance Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Critical Illness Insurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Critical Illness Insurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Critical Illness Insurance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Monthly Premium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Monthly Premium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Monthly Premium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Quarterly Premium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Quarterly Premium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Quarterly Premium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Half Yearly Premium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Half Yearly Premium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Half Yearly Premium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Yearly Premium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Yearly Premium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Yearly Premium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Individual Insurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Individual Insurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Individual Insurance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Family Insurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Family Insurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Family Insurance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Heart Attack by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Heart Attack by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Heart Attack by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Stroke by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Major Organ Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Major Organ Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Major Organ Transplant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Critical Illness Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • JAPAN
    • Critical Illness Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • CHINA
    • Critical Illness Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • EUROPE
    • Critical Illness Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Critical Illness Insurance by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Critical Illness Insurance by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Critical Illness Insurance by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • FRANCE
    • Critical Illness Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • GERMANY
    • Critical Illness Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Critical Illness Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Critical Illness Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Critical Illness Insurance by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Critical Illness Insurance by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Critical Illness Insurance by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Critical Illness Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • INDIA
    • Critical Illness Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Critical Illness Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Critical Illness Insurance by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Critical Illness Insurance by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Critical Illness Insurance by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Critical Illness Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Critical Illness Insurance by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Critical Illness Insurance by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Critical Illness Insurance by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030
  • AFRICA
    • Critical Illness Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Critical Illness Insurance by Premium - Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Critical Illness Insurance by Premium - Percentage Breakdown of Value Sales for Monthly Premium, Quarterly Premium, Half Yearly Premium and Yearly Premium for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Critical Illness Insurance by Type - Individual Insurance and Family Insurance - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Critical Illness Insurance by Type - Individual Insurance and Family Insurance Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Critical Illness Insurance by Type - Percentage Breakdown of Value Sales for Individual Insurance and Family Insurance for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Critical Illness Insurance by Disease - Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Critical Illness Insurance by Disease - Percentage Breakdown of Value Sales for Cancer, Heart Attack, Stroke, Major Organ Transplant and Other Diseases for the Years 2015, 2025 & 2030

IV. COMPETITION